In PDAC, all the cell lines whose LKB1 status is known (6/8) harbor the wild type tumor suppressor and, consistently with the results in NSCLC, upon treatment with the BET inhibitor, downregulation of MYC is preponderant. This evidence concerns the gene MYC and non-small cell lung carcinoma.